Tracheal Infections

  • Amal Isaiah
  • Kevin D. Pereira
  • Armando G. Correa


Infectious processes of the trachea represent a distinct clinical entity with an evolving landscape owing to advances in airway management and vaccination practices. Untreated inflammatory processes of the trachea may present in the form of acute airway obstruction, potentially resulting in significant morbidity and even mortality. Therefore it is important to recognize the cardinal features of some of the common tracheal infectious processes to differentiate them from non-infectious pathology, as the latter is associated with a more indolent course.

As with most other infectious processes of the airway, pathogens causing tracheal infection can be bacterial, viral or fungal in nature. Viral etiology represents the most common cause of laryngotracheal infection in a child. Bacterial infections of the trachea are responsible for more significant morbidity, including prolonged hospitalization, need for endotracheal intubation and even an occasional tracheostomy. The current chapter describes the clinical features and microbiology of tracheal infections at large, explores the utility of diagnostic tests, and provides an algorithm for management.


Tracheitis Croup Stridor Airway obstruction Laryngotracheitis Parainfluenza Steroids Epinephrine Intubation Mist therapy 


A plethora of epidemics , changes in immunization practices and endotracheal intubation have resulted in a better understanding of the pathogenesis of tracheal infections. Historic descriptions first appeared for croup; with the name derived from Anglo-Saxon root kropan referring to a child with a barking cough. This was first described in print as early as 1854 [1]. Much deliberation ensued concerning the treatment of this condition, with O’Dwyer being the first physician credited with treatment of acute croup either by insertion of a modified endotracheal tube [2] or a tracheostomy [3] in separate instances.

The first reported case of tracheitis was published in 1823 by Pierre Blaud [4]. An increase in incidence was observed during each influenza A virus pandemic—H1N1 during the great Spanish flu (1918), Asian flu caused by H2N2 (1957), Hong Kong flu resulting from H3N2 (1968), and more recently the pandemic H1N1 of 2009. Autopsies performed during the 2009 pandemic showed tracheal denudation, maceration, de-epithelialization and other pathologic changes consistent with tracheitis [5]. Bacterial tracheal infections still maintain a low level of presence in infants and children presenting with symptoms of airway obstruction, requiring ICU admission and potentially endotracheal intubation.

Different diagnostic terms have been used for conditions that affect the larynx and trachea. Although it is useful to distinguish between supraglottic and subglottic laryngitis, this distinction is often difficult when the child is first seen. Laryngotracheitis or croup syndrome is a useful preliminary descriptive diagnosis until more definitive information is available [6]. “Croup syndrome” also has been used to emphasize the variety of possible causes and location of laryngotracheal disease. In this chapter, “croup” is used to refer to subglottic laryngitis or laryngotracheitis, presumably viral. “Epiglottitis” is an imprecise term often used in place of the better “supraglottitis” as the epiglottis may be minimally involved in some cases in which most of the swelling is in the aryepiglottic folds. Preferred terms for tracheal infections are (with the usual terms in parentheses): croup, supraglottitis (epiglottitis), and suppurative tracheitis, laryngotracheitis, laryngotracheobronchitis, or laryngotracheobronchopneumonitis (bacterial tracheitis), depending on the extent of the bacterial superinfection [6].


Tracheal infections have a significantly lower incidence compared to infections of the upper respiratory tract, with 1–5 % of all children requiring outpatient evaluation for viral croup within the first 3 years of life. Croup also requires hospital admission in about 1.3–5.6 % of all children evaluated for the same in emergency settings [7, 8].

Viral croup has the highest incidence in the second year of life and is virtually non-existent in the first 3 months. The incidence is slightly higher in male children (odds ratio = 1.43), and is highest in late fall and early winter [7]. A time-series analysis performed from a large number of children admitted with a principal diagnosis of croup in Ontario suggested a strong component of seasonality, with a biennial mid-autumn peak and annual summer trough [9]. Of interest, the overall number of hospitalizations has continued to decrease in the last 20 years, given the improvement in diagnosis and treatment. Marx et al. [10] from the Centers for Disease Control (CDC) studied the overall burden of croup and showed that the mean annual number of croup hospitalizations is about 41,000 (range, 27,000–62,000/year) in the U.S. Ninety-one percent of hospitalizations occur among children <5 years of age. The authors also reported that minor peaks in croup hospitalizations occurred each year in February, and major peaks occurred in October of odd-numbered years, which coincides with peak parainfluenza type 1 activity.

Supraglottitis, in contrast, has no seasonal peak. This disease, almost always caused by Haemophilus influenzae type b and accompanied by bacteremia, has been virtually eradicated by widespread immunization during infancy. While the peak age frequency for croup is 1–3 years, supraglottitis occurs in older children, with a peak between 3 and 6 years. Suppurative tracheobronchitis also tends to be a disease of preschool and school-age children [6].

The reported incidence for bacterial tracheitis in the literature is about 0.1/100,000 [11]. This estimate was based on the combined experience of four pediatric intensive care units. The incidence of tracheal infections caused by other pathogens such as fungal or mycobacterial origin is exceedingly low. Over the last two decades, the availability of nebulized epinephrine as well as injectable corticosteroids have changed the landscape of serious, life-threatening tracheal infections, with the re-emergence of bacterial tracheitis. Currently, bacterial tracheitis has three times the risk of respiratory failure associated with it than epiglottitis and viral croup combined [4].


Acute laryngotracheitis, considered to be the most common cause for croup, is almost exclusively caused by viral organisms. Both bacteria and viruses may be responsible for infections with collateral components, such as laryngotracheobronchitis, and the more general laryngotracheobronchopneumonitis. In 1958, the first evidence for association between croup and two newly isolated myxoviruses, parainfluenza virus types 1 and 2, resulted in separation of two categories of cases—mild, requiring only outpatient follow up, and severe, requiring hospitalization [12]. Parainfluenza is a RNA paramyxovirus that actively replicates in respiratory epithelial cells and is comprised of four major serotypes. Parainfluenza type 3, more commonly associated with bronchiolitis or bronchopneumonia, can also produce severe croup in an endemic pattern, while type 4 is rarely seen. Parainfluenza 1 and 2, account for >65 % of all causes of croup. A large series studied 6165 instances of lower respiratory tract infections (LRIs) wherein approximately 75 % of all isolates were identified as parainfluenza viruses. Of these, parainfluenza type 1 accounted for about 60 %. Conversely, the propensity of the various organisms to produce symptoms of croup reached 60 % for both parainfluenza 1 and 2. For parainfluenza type 3, the number dropped to about 30 %, whereas all the other microorganisms accounted for about 5–15 %. Thus, parainfluenza viruses were the most common cause for all age groups; whereas respiratory syncytial virus (RSV) caused croup in infants and the influenza viruses and M. pneumoniae were significant causes of croup only in children older than 5 years of age. Summertime croup may be due to enteroviruses, adenovirus, or parainfluenza type 3.

Among other important viral pathogens causing tracheal infections, RSV was studied in isolates from sentinel practices in England and Wales from 1975 to 1990, during which an increase in mortality, by as much as 60–80 %, was observed in comparison with parainfluenza and influenza viruses [13]. Prematurity is associated with an increased risk for mortality, with factors such as a decrease in gestational age, increased perinatal oxygen requirements and discharge within 3 months of the RSV season increasing the likelihood for hospitalization [14]. Among the rare viral causes, measles, by virtue of immunosuppression, leads to a bacterial superinfection that results in a condition termed measles-associated bacterial tracheitis (MABT), which carries an increased risk for need of artificial airway and intensive care admission [15].

Bacterial tracheitis is much less common when compared to that of viral origin. Previous reports have shown that the most consistent organism is S. aureus , followed by S. pneumoniae and M. catarrhalis [4]. Due to the universal immunization against H. influenzae type b, the incidence has dropped significantly. Similarly, immunization against C. diphtheriae has restricted the incidence of diphtheritic tracheitis to unimmunized children only. Reports of this are largely limited in modern literature, compared to the beginning of the century when tracheostomy was a routine practice to circumvent acute airway obstruction due to formation of pseudomembranes [16].

Fayon et al. [17] studied independent risk factors for development of bacterial tracheitis in a large series of children admitted to the PICU (n = 955), and found that the incidence of bacterial nosocomial tracheitis in that population was about 1.8 %. The pathogens isolated in this series were in agreement with other studies of bacterial tracheitis, comprising Staphylococcus aureus and gram-negative bacteria, and sometimes, mixed flora. In this population, tracheitis was attributed to young age, with small-sized airways in which thick secretions and mucosal inflammation being blamed for impairment of air flow and increased stasis. Head trauma, neuromuscular blockade and mechanical ventilation were independent variables that increased the risk of infection, but the last two risk factors may be physiologically collinear, given that most patients who were administered neuromuscular blockade were intubated, and vice versa.

Given the evolution of design features of modern day endotracheal tubes as well as enhanced monitoring of cuff pressures, reports of laryngotracheitis induced by indwelling endotracheal tubes have largely been limited to historic data [18]. Modern endotracheal tubes use materials that intrinsically inhibit or are coated with substances such as micronized silver to reduce bacterial growth by providing less scaffolding for colonization [19, 20].

Infectious agents such as Mycobacterium tuberculosis and fungi have been previously reported to have caused isolated instances of tracheal infection with a picture of long-term respiratory failure requiring a tracheostomy during the course of treatment that may be prolonged [21]. Chronic aspiration as well as gastroesophageal reflux (GERD) may accelerate laryngotracheal injury facilitating the development of tracheitis in those children.

Clinical Presentation

Despite the narrow spectrum of pathogens isolated from the plethora of tracheal infections described, these can have varied presentations, and typically differ in the outpatient vis-à-vis inpatient setting.

Acute viral croup manifests in the form of a viral prodrome characterized by clear rhinorrhea, low-grade fever, sore throat (in older children) and cough [22]. This usually lasts about 12–72 h, and typically progresses to hoarseness and the pathognomonic croupy cough that has a bark-like character. Rarely, febrile convulsions can occur. Nighttime symptoms are usually worse which frequently prompts the parents to seek care in the emergency room.

The typical course of progression goes through stridor that is inspiratory in nature but may also be associated with an expiratory component that results from unique features of the larynx in young children [23]. The infant larynx is narrowest in the subglottic segment, and inflammation of this area results in a fixed obstruction that leads to expiratory stridor. Children presenting multiple times with acute viral croup may have a masked presentation of subglottic stenosis wherein the already narrowed subglottic larynx is further reduced in diameter due to croup-related inflammation [24]. Hoarseness results from edema of the true vocal cords, often reducing their mobility. Wheezing is infrequently present. With increased severity, suprasternal and intercostal retractions may be present, and tachycardia and tachypnea are relatively common. It is important to note that reduction in the intensity of stridor in a sick-appearing child may be sign of impending respiratory failure as airflow may be reduced to the point where stridor may not be present.

When an infectious cause is not present in croup, the clinical course is abbreviated, with the noticeable absence of the viral prodrome. This condition is frequently referred as “spasmodic croup”, although episodic croup is a more appropriate term as it is typically triggered by an allergic etiology and often recurs [25]. Pediatric angioedema shares features with croup, but is often associated with facial or neck swelling that is acute in onset [26]. Rarely, an undetected foreign body may masquerade as acute croup. Although a viral prodrome may be absent, an unsuspecting physician may be drawn into an acute airway emergency due to commonality of symptoms [27].

The severity of viral croup may be assessed using one of the many scoring systems available. The most well-known of these, the Westley Croup Score [28], utilizes key clinical signs including chest retractions, stridor, cyanosis, level of consciousness and air entry to obtain a composite score that is predictive of the need for intubation. As croup is primarily a clinical diagnosis, the utility of the Westley Score, as with other stratification systems, such as the Alberta Clinical Practice Guideline Working Group [29], may be limited to use in a research scenario. For example, using the Westley Score, Johnson et al. [30] showed that ≥ 85 % of children present with symptoms of generally mild croup, and less than 1 % were diagnosed with severe croup.

Peltola et al. [31] studied the clinical courses of croup caused by parainfluenza and influenza viruses to highlight the differences in morbidity caused by the different viral strains in hospitalized children. In general, there were no significant differences in the patterns of clinical features due to infections with the three parainfluenza subtypes, except that parainfluenza 3 was associated with wheezing. However, children with croup due to microbiologically-confirmed influenza virus tended to be hospitalized for longer (4 days vs. 2 days for parainfluenza). In addition, the rates of readmission were higher for influenza due to the relapsing course of respiratory distress during the few days following discharge. The requirements for corticosteroids as well as supplemental oxygen also tended to be higher for those caused by influenza virus, emphasizing its enhanced virulence.

Notwithstanding the generally predictable course of viral croup, it is important to differentiate it from other acute disorders of the pediatric airway. Rapidity in progression to high fever, odynophagia, anxiety and relative aphonia should always alert the practitioner to supraglottitis (epiglottitis), which is a rare occurrence following introduction of universal immunization against Hemophilus influenzae type b. Posturing in the upright position and extension of the neck with drooling in an anxious-appearing child mandates the need to secure the airway in a controlled setting such as the operating room. Care should be taken to not agitate the child for that may precipitate respiratory collapse. If there is history to suggest incomplete immunization, laryngeal diphtheria should be considered. This condition tends to have a slower progression, and has historically been associated with the presence of exudative membranes in the oropharynx.

Bacterial tracheitis typically is a secondary infection following a primary viral respiratory infection due to a cascade of events resulting from tracheal mucosal injury, impaired phagocytic function and cytopathic effects of the viral infection. This condition usually is recognized after reasonable efforts to treat viral croup have failed. Children with bacterial tracheitis are acutely ill, with symptoms to suggest dehydration and organ failure in the presence of other host factors such as immunodeficiency. Often seen in an inpatient setting in children admitted to the ICU with respiratory failure, bacterial tracheitis can have a variable presentation in the absence of pathognomonic clinical signs [32].

The cardinal initial signs of bacterial tracheitis include cough, stridor and a rapidly changing course of illness that progresses to respiratory failure quickly. Children affected are usually older (>5 years). Other symptoms on admission may include choking episodes, dyspnea, dysphagia, neck pain, dysphonia and agitation. In one study by Bernstein et al. [33], children younger than 5 years of age were twice as likely to be intubated, compared to older children. The same study compared changing figures for mortality—prior to the 1940s, the mortality rate for bacterial tracheitis approached 40 %, but with advances in mechanical ventilation and airway management, that figure has dropped to 0–20 % in more recent series.

Diagnostic Tests

From the majority of studies, it is clear that the diagnosis of acute viral croup is chiefly based on clinical examination and does not necessitate laboratory testing. That said, if there is suspicion for a concurrent lower respiratory tract infection, white blood cell count with differential, as well as routine postero-anterior/lateral chest and neck radiographs may be indicated. In viral croup, the white count is often at the high end of normal, and may be higher in approximately 50 % of hospitalized children [34]. Administration of corticosteroids may cause leukocyte demargination, which can lead to spuriously elevated counts during the course of treatment.

Plain film radiography often is utilized to evaluate laryngotracheal edema in croup, but has inconsistent results. The typical picture is that of narrowing of laryngeal air column in the subglottic segment, approximately for ~5–10 mm below the level of the vocal cords, resulting from mucosal edema [35]. This has been historically referred to as the steeple sign (Fig. 12.1), but is observed only in ~50 % of instances [23]. This, coupled with reduced sensitivity for differentiating between viral croup, epiglottitis and bacterial tracheitis undermines the usefulness of routine radiographs for diagnosis. However, some investigators such as Mills et al. [36], have reported sensitivity and specificity of >90 % respectively. The best practice in these circumstances is to consider radiographs in those children in whom the clinical presentation is atypical and whose respiratory status is stable enough to undergo positioning prior to obtaining the films [23].
Fig. 12.1

Antero-posterior view of a plain film radiograph showing a long segment of subglottic and tracheal inflammation in a child with croup

Alveolar gas exchange is usually not affected by viral croup, unless there is concurrent presence of laryngotracheobronchitis, asthma or pulmonary insufficiency [23]. Thus, pulse oximetry and respiratory rate have been shown to have poor correlation with clinical status or hypoxia due to artifacts [37]. Evidently, the uncompromised standard is clinical observation with pulse oximetry as a useful adjunct in instances wherein the lower airway is also affected.

In cases where operative control of the airway is required, telescopic tracheobronchoscopy, aided by the ventilating bronchoscope provides the gold standard for assessment of the airway in severe croup, or when alternate pathology, such as supraglottitis, is suspected. In the ambulatory setting, children who present with recurrent croup should be examined for concurrent abnormalities. Chun et al. [38] evaluated 30 children who were previously diagnosed with recurrent episodes of croup. A third of these children were found to have synchronous lesions such as subglottic stenosis, edema and cysts. In the same study, abnormal rigid endoscopic findings were more likely to be seen in children under the age of 3 years, highlighting the need for a higher index of suspicion and lower threshold for performing airway endoscopy in this age group.

Microbiologic investigations to determine etiology are increasingly being performed due to the availability of molecular and standard virologic methods. These tests are usually not recommended for diagnosis in mild cases of croup, but may be warranted in children hospitalized and/or requiring mechanical ventilation. Real-time polymerase chain reaction (RT-PCR) and viral cultures are also indicated with atypical courses of the infection, as described by reports of novel pathogenic strains for viral croup, e.g. coronavirus NL63 detected in samples isolated from Europe [39]. An improved panel based on an RT-PCR assay has been developed for influenza A and B viruses, RSV and parainfluenza 1, 2, 3 and 4. According to one study, the application of PCR increases the sensitivity of respiratory viral diagnosis, with results being made available within 6 h, thus increasing clinical relevance [40]. With claimed sensitivity of ~80 % and specificity approaching 100 %, several authors have increasingly validated their cost-effectiveness [41]. As mentioned earlier, the routine use of these tests in mild croup is unsubstantiated.

In children undergoing rigid endoscopy or endotracheal intubation for bacterial tracheitis and other serious airway infections, routine contact bacterial cultures and broncho-alveolar lavage with cultures may be obtained to facilitate culture-directed therapy. Jones et al. [42] first described laryngoscopically-directed cultures in bacterial tracheitis from copious mucopurulent material obtained from the subglottis, which grew S. aureus in most instances (Fig. 12.2). Plain film radiographs in these instances are consistent with progression of an inflammatory response (Fig. 12.3). These results have been replicated from a number of other centers [32, 43, 44].
Fig. 12.2

Endoscopic photographs of (a) early bacterial tracheitis, with increase in exudates seen in the subglottis without overt purulence, (b) crusting and purulence seen that progressed to (c) erythema, pseudomembranes and overall inflamed-appearing tracheal mucosa

Fig. 12.3

Lateral plain firm radiograph showing marked haziness in the air column within the trachea, signifying ongoing inflammation. Arrows point to anatomical changes that can be due to ongoing tracheal inflammation


The treatment of tracheal infections has evolved over the course of the twentieth century, from initial descriptions of primitive endotracheal intubation to tracheostomy performed for acute airway distress secondary to laryngeal diphtheria [1, 2, 3]. The first recognized form of treatment was the use of mist (humidified aerosol) produced by hot water, historically reported by keeping children close to a running tub with the door closed, leading to accumulation of mist. Discovery of therapeutic benefits from the use of corticosteroids and racemic epinephrine have revolutionized the manner in which croup is treated, and advanced in mechanical ventilation as well as development of rigid telescopes have improved treatment of tracheal infections of bacterial origin as well. These therapeutic strategies are summarized below.

Use of Humidified Air

Croup kettles were first introduced in the late nineteenth century to provide aerosolized mist to alleviate the symptoms of viral croup [45]. Later, cool mist was observed to have the same degree of therapeutic benefit as warm mist, and this avoids the risk of burns. There are at least three postulated mechanisms, which include (i) a soothing effect on inflamed mucosa, (ii) reduced viscosity of tracheal secretions and (iii) activation of laryngeal mechanoreceptors leading to reduction of turbulence [23]. However, humidity may also trigger bronchospasm, thus the duration of therapy should be carefully monitored. Recent studies have, however, shown that the benefits offered by mist treatment may be overemphasized. Three separate studies, that did not include untreated controls, determined that the efficacy of aerosolized mist may not be proportional to the degree of mist saturation, for e.g. the effects of humidity at three different levels (100 %, 40 % and 33 %) remained the same [46]. In yet another study, the effect of nebulized saline was identical to mist. Lastly, a recent Cochrane review of data concluded that the benefit of mist therapy remains unproven [47].

Use of Corticosteroids

Despite the various recommendations for dosages, routes and drugs for use of corticosteroids, a number of large-scale studies have exemplified their therapeutic efficacy. Their mechanism of action is related to the reduction of vascular permeability, resulting in a reduction of laryngeal and tracheal mucosal inflammation. Russell et al. [48] in a Cochrane Collaboration reviewed 38 studies and showed that corticosteroids resulted in a rapid improvement of Westley score, fewer return visits and/or readmissions, reduction of stay in the emergency room as well as the overall need for concurrent use of epinephrine. The benefits are not readily apparent in children with mild croup as the symptoms begin to resolve in about the same time taken for steroids to show treatment benefit.

Following adoption of corticosteroids as a standard first line of therapy in acute viral croup, overall hospitalization and the burden of the disease on healthcare systems worldwide began to fall. This was acknowledged following the guidelines formulated by the Canadian Pediatric Society that encouraged the use of intravenous dexamethasone as initial treatment of croup [9]. Among steroids, dexamethasone is used in a dose of 0.6 mg · Kg−1 body weight given either orally or by the intramuscular route. As dexamethasone is a potent steroid with a prolonged half-life, repeat doses are often unnecessary.

Other investigators have shown that orally administered dexamethasone is as efficacious as parenteral formulations. The choice of route should hence be determined based on cost and availability. Yet another study failed to show differences in therapeutic benefit between three different doses (0.15, 0.3 and 0.6 mg · Kg−1) of dexamethasone, so a single dose (0.6 mg · Kg−1; maximum of 8 mg) may be sufficient in the outpatient setting [49]. A double-blind, randomized control trial compared three different treatment strategies that included placebo, nebulized budesonide and oral dexamethasone [50]. In this study, the overall rates of hospitalization were much less in the group treated with dexamethasone (23 %), compared with budesonide (38 %) and far less compared with placebo (77 %). Other studies have also advocated for the use of aerosolized budesonide given the rapidity of its action and effectiveness comparable to that of nebulized epinephrine [51, 52].

Use of Epinephrine

The primary benefit offered by the use of aerosolized/nebulized epinephrine is the reduced need for intubation. Early studies showed immediate clinical benefit with use of 2.25 % racemic epinephrine, and the more recent studies demonstrated the same amount of benefit for L-epinephrine at a ratio of 1:1000 used with 5 mL saline [53]. Initial studies represented a major paradigm shift in management of children with severe croup, obviating the need for endotracheal intubation or tracheostomy [54]. The therapeutic effects of epinephrine are mediated via α-adrenergic receptors that results in constriction of capillary arterioles and reduced inflammation. Unfortunately, although the effects are almost immediate, they only last approximately 2 h, and hence the child should be watched for a reasonable period of time prior to discharge. This therapy may be suitable even in the outpatient setting if the observation period is adequate, although lack of improvement at about an hour following treatment may convert an outpatient encounter to hospitalization [55]. When conditions such as tetralogy of Fallot, tachycardia or ventricular outlet obstruction co-exist, epinephrine should be used cautiously [23]. With the peak effect occurring between 30 and 60 min, the child should be carefully monitored for the rebound effect—which usually occurs 3 h after treatment. The recommended dose is thus 2.25 % (0.25 mL in 3.75 mL of saline) for children <6 months of age and 0.5 mL for infants and children >6 months. Substituting isotonic with hypertonic saline (3 %) may enhance the effect by absorbing water from the submucosa.

Other Therapies

When respiratory failure is impending (cyanosis, severe retractions with lack of airflow, and persistent desaturations), endotracheal intubation is indicated until laryngeal edema resolves. This is usually transient and rarely evolves into a need for long-term mechanical ventilation, In children treated with steroids during the course of intubation, the time to extubation is shortened and the need for reintubation also is reduced [56]. Use of the physiologic leak test, by either vocalization around the cuff, or sustained difference in inspiratory and expiratory tidal volumes serves as a guide for extubation in these children.

Since its description in 1979, use of helium as a carrier for oxygen (heliox) has beneficial effects in reducing eddy currents that interact with each other and thereby reduce turbulent flow. Heliox is routinely used in children with post-extubation stridor to reduce the risk of re-intubation. As an appreciable number of children with severe croup progress to respiratory failure needing an artificial airway, using heliox can reduce the work of breathing by easing the delivery of oxygen to the lower airway past the site of obstruction. Assessments with Croup Scores and blood gas analyses reaffirm the beneficial role of heliox as a useful adjunct to potentially circumvent the need for endotracheal intubation [57]. A randomized trial showed benefit comparable to racemic epinephrine in moderate to severe croup [58].

As the etiology of croup is not bacterial, there is no role for routine use of antibiotics. In the past, inappropriately prescribed antibiotics have been reported to cause superinfections, prolongation of hospital stay as well as general increase in costs [29]. However, when the diagnosis of bacterial tracheitis is strongly suspected, the management changes wherein culture-directed antibiotic therapy is the gold standard of treatment. Empiric therapy with coverage that includes S. aureus, S. pyogenes, S. pneumoniae and H. influenzae is indicated. In an era when both hospital-acquired and community-acquired methicillin-resistant S. aureus (MRSA) are prevalent, the combination of vancomycin and a third generation cephalosporin (such as cefotaxime or ceftriaxone) is a reasonable choice until identification and susceptibility of the causative organism is established. In an intubated patient, tracheal aspirates should be obtained. A very useful adjunct to anti-microbial therapy is the use of frequent pulmonary toilet and debridement of tracheal pseudomembranes under bronchoscopic guidance [59]. In the presence of other co-morbidities such as immunosuppression, mortality increases. Reported complications of bacterial tracheitis include pneumomediastinum, sepsis and multi-organ failure, bronchospasm and impaired gas-exchange due to the burden of pseudomembranes with toxic shock syndrome [60]. Severe croup caused by influenza viruses as a part of epidemics may require treatment with neuraminidase inhibitors [61].

With the increasing number of options to treat croup, an algorithm is useful to stratify the burden of the disease and dictate an appropriate protocol. This is shown in Fig. 12.4.
Fig. 12.4

Algorithm to treat croup in the outpatient setting. (From The New England Journal of Medicine. Cherry JD, Clinical practice. Croup. Vol. 358, pp. 384–91 [62]. © 2008 Massachusetts Medical Society. Reprinted with permission from the Massachusetts Medical Society.)


Despite the relative commonality of laryngotracheal infections, there are no clearly defined guidelines by national organizations for their treatment. The clinical picture can be often frightening to the parents who bring the child to the emergency room. Fortunately, the vast majority of children show signs of rapid improvement after initiation of treatment using steroids and racemic epinephrine. Only a very small proportion of children require hospitalization and an even smaller proportion require intubation and mechanical ventilation. Complications are rare exceedingly rare. In contrast, bacterial tracheitis may have varied presentations and often requires endotracheal intubation and debridement in the operating room. Mortality is higher but early institution of culture-directed therapy is known to reduce the severity of disease and the incidence of complications. It is important for the astute clinician to recognize the symptoms of croup and maintain a high index of suspicion for conditions that masquerade as croup, such as a foreign body, supraglottitis (epiglottitis), subglottic stenosis and other anatomic abnormalities.


  1. 1.
    Green H. Remarks on croup and its treatment. New York: Baker, Godwin & Company, printers; 1854.Google Scholar
  2. 2.
    O’Dwyer J. Fifty cases of croup in private practice treated by intubation of the larynx, with a description of the method and of the dangers incident thereto. Med Rec. 1887;32:557–61.Google Scholar
  3. 3.
    Talbot I. Tracheotomy in croup. N Engl Med Gazette. 1866;1:18.Google Scholar
  4. 4.
    Hopkins A, Lahiri T, Salerno R, Heath B. Changing epidemiology of life-threatening upper airway infections: the reemergence of bacterial tracheitis. Pediatrics. 2006;118(4):1418–21.CrossRefPubMedGoogle Scholar
  5. 5.
    Gill JR, Sheng ZM, Ely SF, Guinee DG, Beasley MB, Suh J, et al. Pulmonary pathologic findings of fatal 2009 pandemic influenza A/H1N1 viral infections. Arch Pathol Lab Med. 2010;134(2):235–43.PubMedCentralPubMedGoogle Scholar
  6. 6.
    Fisher RG, Boyce TG, Moffet HL. Moffet’s pediatric infectious diseases: a problem-oriented approach. Philadelphia: Lippincott Williams & Wilkins; 2005.Google Scholar
  7. 7.
    Denny FW, Murphy TF, Clyde Jr WA, Collier AM, Henderson FW. Croup: an 11-year study in a pediatric practice. Pediatrics. 1983;71(6):871–6.PubMedGoogle Scholar
  8. 8.
    McConnochie KM, Hall CB, Barker WH. Lower respiratory tract illness in the first two years of life: epidemiologic patterns and costs in a suburban pediatric practice. Am J Public Health. 1988;78(1):34–9.PubMedCentralCrossRefPubMedGoogle Scholar
  9. 9.
    Segal AO, Crighton EJ, Moineddin R, Mamdani M, Upshur RE. Croup hospitalizations in Ontario: a 14-year time-series analysis. Pediatrics. 2005;116(1):51–5.CrossRefPubMedGoogle Scholar
  10. 10.
    Marx A, Torok TJ, Holman RC, Clarke MJ, Anderson LJ. Pediatric hospitalizations for croup (laryngotracheobronchitis): biennial increases associated with human parainfluenza virus 1 epidemics. J Infect Dis. 1997;176(6):1423–7.CrossRefPubMedGoogle Scholar
  11. 11.
    Tebruegge M, Pantazidou A, Thorburn K, Riordan A, Round J, De Munter C, et al. Bacterial tracheitis: a multi-centre perspective. Scand J Infect Dis. 2009;41(8):548–57.CrossRefPubMedGoogle Scholar
  12. 12.
    Vargosko AJ, Chanock RM, Huebner RJ, Luckey AH, Kim HW, Cumming C, et al. Association of type 2 hemadsorption (parainfluenza 1) virus and Asian influenza a virus with infections croup. N Engl J Med. 1959;261(1):1–9.CrossRefPubMedGoogle Scholar
  13. 13.
    Nicholson KG. Impact of influenza and respiratory syncytial virus on mortality in England and Wales from January 1975 to December 1990. Epidemiol Infect. 1996;116(1):51–63.PubMedCentralCrossRefPubMedGoogle Scholar
  14. 14.
    Joffe S, Escobar GJ, Black SB, Armstrong MA, Lieu TA. Rehospitalization for respiratory syncytial virus among premature infants. Pediatrics. 1999;104(4 Pt 1):894–9.CrossRefPubMedGoogle Scholar
  15. 15.
    Conley SF, Beste DJ, Hoffmann RG. Measles-associated bacterial tracheitis. Pediatr Infect Dis J. 1993;12(5):414–5.CrossRefPubMedGoogle Scholar
  16. 16.
    Berner R, Leititis JU, Furste HO, Brandis M. Bacterial tracheitis caused by Corynebacterium diphtheriae. Eur J Pediatr. 1997;156(3):207–8.CrossRefPubMedGoogle Scholar
  17. 17.
    Fayon MJ, Tucci M, Lacroix J, Farrell CA, Gauthier M, Lafleur L, et al. Nosocomial pneumonia and tracheitis in a pediatric intensive care unit: a prospective study. Am J Respir Crit Care Med. 1997;155(1):162–9.CrossRefPubMedGoogle Scholar
  18. 18.
    Jordan WS, Graves CL, Elwyn RA. New therapy for postintubation laryngeal edema and tracheitis in children. JAMA. 1970;212(4):585–8.CrossRefPubMedGoogle Scholar
  19. 19.
    Rello J, Kollef M, Diaz E, Sandiumenge A, del Castillo Y, Corbella X, et al. Reduced burden of bacterial airway colonization with a novel silver-coated endotracheal tube in a randomized multiple-center feasibility study. Crit Care Med. 2006;34(11):2766–72.CrossRefPubMedGoogle Scholar
  20. 20.
    Bauer TT, Torres A, Ferrer R, Heyer CM, Schultze-Werninghaus G, Rasche K. Biofilm formation in endotracheal tubes. Association between pneumonia and the persistence of pathogens. Monaldi Arch Chest Dis. 2002;57(1):84–7.PubMedGoogle Scholar
  21. 21.
    Graf J, Stein F. Tracheitis in pediatric patients. Semin Pediatr Infect Dis. 2006;17(1):11–3.CrossRefPubMedGoogle Scholar
  22. 22.
    Knutson D, Aring A. Viral croup. Am Fam Physician. 2004;69(3):535–40.PubMedGoogle Scholar
  23. 23.
    Malhotra A, Krilov LR. Viral croup. Pediatr Rev. 2001;22(1):5–12.CrossRefPubMedGoogle Scholar
  24. 24.
    Holinger P, Kutnick S, Schild J, Holinger L. Subglottic stenosis in infants and children. Ann Otol Rhinol Laryngol. 1975;85(5 Pt. 1):591–9.Google Scholar
  25. 25.
    Koren G, Frand M, Barzilay Z, MacLeod SM. Corticosteroid treatment of laryngotracheitis v spasmodic croup in children. Am J Dis Child. 1983;137(10):941–4.PubMedGoogle Scholar
  26. 26.
    Shah UK, Jacobs IN. Pediatric angioedema: ten years’ experience. Arch Otolaryngol Head Neck Surg. 1999;125(7):791–5.CrossRefPubMedGoogle Scholar
  27. 27.
    Gay Jr BB, Atkinson GO, Vanderzalm T, Harmon JD, Porubsky ES. Subglottic foreign bodies in pediatric patients. Am J Dis Child. 1986;140(2):165–8.PubMedGoogle Scholar
  28. 28.
    Westley CR, Cotton EK, Brooks JG. Nebulized racemic epinephrine by IPPB for the treatment of croup: a double-blind study. Am J Dis Child. 1978;132(5):484–7.CrossRefPubMedGoogle Scholar
  29. 29.
    Wang EE, Einarson TR, Kellner JD, Conly JM. Antibiotic prescribing for Canadian preschool children: evidence of overprescribing for viral respiratory infections. Clin Infect Dis. 1999;29(1):155–60.CrossRefPubMedGoogle Scholar
  30. 30.
    Johnson DW. Croup. BMJ Clin Evid. 2009;2009:0321.PubMedCentralPubMedGoogle Scholar
  31. 31.
    Peltola V, Heikkinen T, Ruuskanen O. Clinical courses of croup caused by influenza and parainfluenza viruses. Pediatr Infect Dis J. 2002;21(1):76–8.CrossRefPubMedGoogle Scholar
  32. 32.
    Miranda AD, Valdez TA, Pereira KD. Bacterial tracheitis: a varied entity. Pediatr Emerg Care. 2011;27(10):950–3.CrossRefPubMedGoogle Scholar
  33. 33.
    Bernstein T, Brilli R, Jacobs B. Is bacterial tracheitis changing? A 14-month experience in a pediatric intensive care unit. Clin Infect Dis. 1998;27(3):458–62.CrossRefPubMedGoogle Scholar
  34. 34.
    Postma DS, Jones RO, Pillsbury 3rd HC. Severe hospitalized croup: treatment trends and prognosis. Laryngoscope. 1984;94(9):1170–5.CrossRefPubMedGoogle Scholar
  35. 35.
    Kaditis AG, Wald ER. Viral croup: current diagnosis and treatment. Pediatr Infect Dis J. 1998;17(9):827–34.CrossRefPubMedGoogle Scholar
  36. 36.
    Mills JL, Spackman TJ, Borns P, Mandell GA, Schwartz MW. The usefulness of lateral neck roentgenograms in laryngotracheobronchitis. Am J Dis Child. 1979;133(11):1140–2.PubMedGoogle Scholar
  37. 37.
    Stoney PJ, Chakrabarti MK. Experience of pulse oximetry in children with croup. J Laryngol Otol. 1991;105(4):295–8.CrossRefPubMedGoogle Scholar
  38. 38.
    Chun R, Preciado DA, Zalzal GH, Shah RK. Utility of bronchoscopy for recurrent croup. Ann Otol Rhinol Laryngol. 2009;118(7):495–9.CrossRefPubMedGoogle Scholar
  39. 39.
    van der Hoek L, Sure K, Ihorst G, Stang A, Pyrc K, Jebbink MF, et al. Croup is associated with the novel coronavirus NL63. PLoS Med. 2005;2(8), e240.PubMedCentralCrossRefPubMedGoogle Scholar
  40. 40.
    Templeton KE, Scheltinga SA, Beersma MF, Kroes AC, Claas EC. Rapid and sensitive method using multiplex real-time PCR for diagnosis of infections by influenza a and influenza B viruses, respiratory syncytial virus, and parainfluenza viruses 1, 2, 3, and 4. J Clin Microbiol. 2004;42(4):1564–9.PubMedCentralCrossRefPubMedGoogle Scholar
  41. 41.
    Syrmis MW, Whiley DM, Thomas M, Mackay IM, Williamson J, Siebert DJ, et al. A sensitive, specific, and cost-effective multiplex reverse transcriptase-PCR assay for the detection of seven common respiratory viruses in respiratory samples. J Mol Diagn. 2004;6(2):125–31.PubMedCentralCrossRefPubMedGoogle Scholar
  42. 42.
    Jones R, Santos JI, Overall Jr JC. Bacterial tracheitis. JAMA. 1979;242(8):721–6.CrossRefPubMedGoogle Scholar
  43. 43.
    Salamone FN, Bobbitt DB, Myer CM, Rutter MJ, Greinwald Jr JH. Bacterial tracheitis reexamined: is there a less severe manifestation? Otolaryngol Head Neck Surg. 2004;131(6):871–6.CrossRefPubMedGoogle Scholar
  44. 44.
    Liston SL, Gehrz RC, Jarvis CW. Bacterial tracheitis. Arch Otolaryngol. 1981;107(9):561–4. Chicago, Ill: 1960.CrossRefPubMedGoogle Scholar
  45. 45.
    Porter L. Management of the sick infant. South Med J. 1927;20(7):576.CrossRefGoogle Scholar
  46. 46.
    Scolnik D, Coates AL, Stephens D, Da Silva Z, Lavine E, Schuh S. Controlled delivery of high vs low humidity vs mist therapy for croup in emergency departments: a randomized controlled trial. JAMA. 2006;295(11):1274–80.CrossRefPubMedGoogle Scholar
  47. 47.
    Moore M, Little P. Humidified air inhalation for treating croup. Cochrane Database Syst Rev. 2006;3, CD002870.PubMedGoogle Scholar
  48. 48.
    Russell KF, Liang Y, O’Gorman K, Johnson DW, Klassen TP. Glucocorticoids for croup. Cochrane Database Syst Rev. 2011;1, CD001955.PubMedGoogle Scholar
  49. 49.
    Rittichier KK, Ledwith CA. Outpatient treatment of moderate croup with dexamethasone: intramuscular versus oral dosing. Pediatrics. 2000;106(6):1344–8.CrossRefPubMedGoogle Scholar
  50. 50.
    Johnson DW, Jacobson S, Edney PC, Hadfield P, Mundy ME, Schuh S. A comparison of nebulized budesonide, intramuscular dexamethasone, and placebo for moderately severe croup. N Engl J Med. 1998;339(8):498–503.CrossRefPubMedGoogle Scholar
  51. 51.
    Fitzgerald D, Mellis C, Johnson M, Allen H, Cooper P, Van Asperen P. Nebulized budesonide is as effective as nebulized adrenaline in moderately severe croup. Pediatrics. 1996;97(5):722–5.PubMedGoogle Scholar
  52. 52.
    Klassen TP, Feldman ME, Watters LK, Sutcliffe T, Rowe PC. Nebulized budesonide for children with mild-to-moderate croup. N Engl J Med. 1994;331(5):285–9.CrossRefPubMedGoogle Scholar
  53. 53.
    Cherry JD. State of the evidence for standard-of-care treatments for croup: are we where we need to be? Pediatr Infect Dis J. 2005;24(11 Suppl):S198–202; discussion S1.CrossRefPubMedGoogle Scholar
  54. 54.
    Adair JC, Ring WH, Jordan WS, Elwyn RA. Ten-year experience with IPPB in the treatment of acute laryngotracheobronchitis. Anesth Analg. 1971;50(4):649–55.CrossRefPubMedGoogle Scholar
  55. 55.
    Prendergast M, Jones JS, Hartman D. Racemic epinephrine in the treatment of laryngotracheitis: can we identify children for outpatient therapy? Am J Emerg Med. 1994;12(6):613–6.CrossRefPubMedGoogle Scholar
  56. 56.
    Tibballs J, Shann FA, Landau LI. Placebo-controlled trial of prednisolone in children intubated for croup. Lancet. 1992;340(8822):745–8.CrossRefPubMedGoogle Scholar
  57. 57.
    Duncan PG. Efficacy of helium—oxygen mixtures in the management of severe viral and post-intubation croup. Can Anaesth Soc J. 1979;26(3):206–12.CrossRefPubMedGoogle Scholar
  58. 58.
    Weber JE, Chudnofsky CR, Younger JG, Larkin GL, Boczar M, Wilkerson MD, et al. A randomized comparison of helium-oxygen mixture (Heliox) and racemic epinephrine for the treatment of moderate to severe croup. Pediatrics. 2001;107(6), E96.CrossRefPubMedGoogle Scholar
  59. 59.
    Sofer S, Duncan P, Chernick V. Bacterial tracheitis—an old disease rediscovered. Clin Pediatr. 1983;22(6):407–11.CrossRefGoogle Scholar
  60. 60.
    Kasian GF, Bingham WT, Steinberg J, Ninan A, Sankaran K, Oman-Ganes L, et al. Bacterial tracheitis in children. CMAJ. 1989;140(1):46–50.PubMedCentralPubMedGoogle Scholar
  61. 61.
    Bridges CB, Harper SA, Fukuda K, Uyeki TM, Cox NJ, Singleton JA. Prevention and control of influenza. Recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR Recomm Rep. 2003;52(RR-8):1–34; quiz CE1–4.Google Scholar
  62. 62.
    Cherry JD. Clinical practice. Croup. N Engl J Med. 2008;358(4):384–91.CrossRefPubMedGoogle Scholar

Copyright information

© Springer International Publishing Switzerland 2016

Authors and Affiliations

  • Amal Isaiah
    • 1
  • Kevin D. Pereira
    • 1
    • 2
  • Armando G. Correa
    • 3
    • 4
  1. 1.Department of Otorhinolaryngology—Head and Neck SurgeryUniversity of Maryland School of MedicineBaltimoreUSA
  2. 2.Department of Pediatric OtolaryngologyUniversity of Maryland School of MedicineBaltimoreUSA
  3. 3.Department of PediatricsBaylor College of MedicineHoustonUSA
  4. 4.Texas Children’s HospitalHoustonUSA

Personalised recommendations